Skip to content
10-K

Annual Report

UroGen Pharma Ltd. URGN

0001437749-25-006842

← back to feed
Filed
Mar 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 3, 2025 46.09M sh
Eps Basic FY 2024 · Dec 31, 2024 −$0.80
Eps Basic FY 2024 · Sep 30, 2024 −$0.51
Eps Basic FY 2024 · Sep 30, 2024 −$2.15
Eps Basic FY 2024 · Jun 30, 2024 −$0.82
Eps Basic FY 2024 · Jun 30, 2024 −$1.69
Eps Basic FY 2024 · Mar 31, 2024 −$0.87
Eps Basic FY 2024 · Dec 31, 2023 −$0.72
Eps Basic FY 2024 · Dec 31, 2023 −$3.55
Eps Basic FY 2024 · Sep 30, 2023 −$0.68
Eps Basic FY 2024 · Sep 30, 2023 −$2.89
Eps Basic FY 2024 · Jun 30, 2023 −$1.03
Eps Basic FY 2024 · Jun 30, 2023 −$2.33
Eps Basic FY 2024 · Mar 31, 2023 −$1.30
Net Income FY 2024 · Dec 31, 2024 −$37.51M
Net Income FY 2024 · Sep 30, 2024 −$23.67M
Net Income FY 2024 · Sep 30, 2024 −$89.36M
Net Income FY 2024 · Jun 30, 2024 −$33.4M
Net Income FY 2024 · Jun 30, 2024 −$65.69M
Net Income FY 2024 · Mar 31, 2024 −$32.29M
Net Income FY 2024 · Dec 31, 2023 −$26.02M
Net Income FY 2024 · Dec 31, 2023 −$102.24M
Net Income FY 2024 · Sep 30, 2023 −$21.88M
Net Income FY 2024 · Sep 30, 2023 −$76.23M
Net Income FY 2024 · Jun 30, 2023 −$24.14M
Net Income FY 2024 · Jun 30, 2023 −$54.35M
Net Income FY 2024 · Mar 31, 2023 −$30.21M
Gross Profit FY 2024 · Dec 31, 2024 $22.09M
Gross Profit FY 2024 · Sep 30, 2024 $22.75M
Gross Profit FY 2024 · Sep 30, 2024 $59.42M
Gross Profit FY 2024 · Jun 30, 2024 $19.62M
Gross Profit FY 2024 · Jun 30, 2024 $36.67M
Gross Profit FY 2024 · Mar 31, 2024 $17.05M
Gross Profit FY 2024 · Dec 31, 2023 $21.24M
Gross Profit FY 2024 · Dec 31, 2023 $73.35M
Gross Profit FY 2024 · Sep 30, 2023 $18.49M
Gross Profit FY 2024 · Sep 30, 2023 $52.11M
Gross Profit FY 2024 · Jun 30, 2023 $18.7M
Gross Profit FY 2024 · Jun 30, 2023 $33.62M
Gross Profit FY 2024 · Mar 31, 2023 $14.93M
Revenue FY 2024 · Dec 31, 2024 $24.57M
Revenue FY 2024 · Sep 30, 2024 $25.2M
Revenue FY 2024 · Sep 30, 2024 $65.83M
Revenue FY 2024 · Jun 30, 2024 $21.85M
Revenue FY 2024 · Jun 30, 2024 $40.63M
Revenue FY 2024 · Mar 31, 2024 $18.78M
Revenue FY 2024 · Dec 31, 2023 $23.53M
Revenue FY 2024 · Dec 31, 2023 $82.71M
Revenue FY 2024 · Sep 30, 2023 $20.85M
Revenue FY 2024 · Sep 30, 2023 $59.18M
Revenue FY 2024 · Jun 30, 2023 $21.14M
Revenue FY 2024 · Jun 30, 2023 $38.33M
Revenue FY 2024 · Mar 31, 2023 $17.19M
Capex FY 2024 · Dec 31, 2023 $194K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$76.38M
Long Term Debt FY 2024 · Dec 31, 2023 $98.55M
Short Term Investments FY 2024 · Dec 31, 2023 $56.16M
Cash And Equivalents FY 2024 · Dec 31, 2023 $95M
Current Liabilities FY 2024 · Dec 31, 2023 $31.21M
Total Liabilities FY 2024 · Dec 31, 2023 $243.52M
Current Assets FY 2024 · Dec 31, 2023 $169.19M
Total Assets FY 2024 · Dec 31, 2023 $178.31M
Sga Expense FY 2024 · Dec 31, 2023 $93.27M
Rd Expense FY 2024 · Dec 31, 2023 $45.61M
Operating Income FY 2024 · Dec 31, 2023 −$65.54M
Cost Of Revenue FY 2024 · Dec 31, 2023 $9.36M
Stockholders Equity FY 2024 · Dec 31, 2022 −$89.36M